<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01115621</url>
  </required_header>
  <id_info>
    <org_study_id>ZI310/14-1</org_study_id>
    <nct_id>NCT01115621</nct_id>
  </id_info>
  <brief_title>BABYDIET-Study - Primary Prevention of Type 1 Diabetes in Relatives at Increased Genetic Risk</brief_title>
  <official_title>BABYDIET-Study - Primary Prevention of Type 1 Diabetes in Relatives at Increased Genetic Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut fur Diabetesforschung, Munich, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut fur Diabetesforschung, Munich, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The major goals of this project are to determine whether primary intervention through delayed
      introduction of dietary gluten is feasible and could reduce the incidence of islet
      autoimmunity in high-risk first degree relatives of patients with type 1 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2001</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of dietary intervention on the development of islet autoantibodies</measure>
    <time_frame>3 years</time_frame>
    <description>Primary outcome is to compare the prevalence of iselt autoantibodies between children participating in the dietary intervention and the control group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of dietary intervention on the development of Type 1 diabetes.</measure>
    <time_frame>10 years</time_frame>
    <description>Secondary outcome is to compare the prevalence of type 1 diabetes between children participating in the dietary intervention and the control group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Glutenfree diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Glutenfree diet during the first year of life</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control - normal diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glutenfree diet during the first year of life</intervention_name>
    <description>Glutenfree diet during the first year of life</description>
    <arm_group_label>Glutenfree diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newborn offspring or siblings of patients with type 1 diabetes with a HLA genotype
             conferring a high diabetes risk

        Exclusion Criteria:

          -  If infants have an illness or birth defect that precludes long-term follow-up or
             involves use of treatment that may alter the natural history of diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anette G Ziegler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut für Diabetesforschung, München, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut für Diabetesforschung</name>
      <address>
        <city>München</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Winkler C, Hummel S, Pflüger M, Ziegler AG, Geppert J, Demmelmair H, Koletzko B. The effect of maternal T1DM on the fatty acid composition of erythrocyte phosphatidylcholine and phosphatidylethanolamine in infants during early life. Eur J Nutr. 2008 Apr;47(3):145-52. doi: 10.1007/s00394-008-0708-9. Epub 2008 Apr 28.</citation>
    <PMID>18443841</PMID>
  </reference>
  <reference>
    <citation>Pflüger M, Winkler C, Hummel S, Ziegler AG. Early infant diet in children at high risk for type 1 diabetes. Horm Metab Res. 2010 Feb;42(2):143-8. doi: 10.1055/s-0029-1241830. Epub 2009 Nov 9.</citation>
    <PMID>19902403</PMID>
  </reference>
  <results_reference>
    <citation>Schmid S, Buuck D, Knopff A, Bonifacio E, Ziegler AG. BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with Type 1 diabetes by delaying exposure to gluten. Diabetologia. 2004 Jun;47(6):1130-1. Epub 2004 May 28.</citation>
    <PMID>15168019</PMID>
  </results_reference>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2010</study_first_submitted>
  <study_first_submitted_qc>April 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2010</study_first_posted>
  <last_update_submitted>April 30, 2010</last_update_submitted>
  <last_update_submitted_qc>April 30, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 4, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Anette-G. Ziegler</name_title>
    <organization>Institut fuer Diabetesforschung, Ingolstädter Landstr. 1, Neuherberg</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

